News

• Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States
  02:30 - GlobeNewswire
•  
• Sunstone makes €5 million investment into Finnish women's health company Forendo Pharma to finance clinical studies in endometriosis
  07/17/2019 / 15:00 - GlobeNewswire
•  
• Global Zoonotic Disease Treatment Market 2017-2025: Focus on Rabies, Viral Hepatitis, Tuberculosis, and Other Disease Types
  07/17/2019 / 14:15 - GlobeNewswire
•  
• Vectura confirms R&D investment priorities, announces a proposed £50 million capital return and a pre-close trading update
  07/17/2019 / 13:00 - GlobeNewswire
•  
• FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)
  07/16/2019 / 07:15 - GlobeNewswire
•  
• Novartis, Amgen and Banner Alzheimer's Institute discontinue clinical program with BACE inhibitor CNP520 for Alzheimer's prevention
  07/11/2019 / 22:30 - GlobeNewswire
•  
• InveniAI Appoints Industry Veteran Dr. Amit Agrawal to Board of Directors and Expands its Operations into the EU
  07/02/2019 / 14:31 - GlobeNewswire
•  
• Novartis successfully completes acquisition of Xiidra®, bolstering ophthalmic portfolio
  07/01/2019 / 17:30 - GlobeNewswire
•  
• Novartis continues to innovate in CML with long-term treatment-free remission results following Tasigna® use and promising combination data with investigational compound asciminib (ABL001)
  06/14/2019 / 08:30 - GlobeNewswire
•  
• Cosentyx® provides long-lasting inhibition of radiographic progression in psoriatic arthritis, new Novartis data show
  06/12/2019 / 07:20 - GlobeNewswire
•  
• Novartis Cosentyx® first to show efficacy in all key manifestations of psoriatic arthritis
  06/12/2019 / 07:15 - GlobeNewswire
•  
• Novartis names new pharma unit head
  06/07/2019 / 07:41 - TeleTrader
•  
• Novartis announces new leader of Pharmaceuticals Business Unit
  06/07/2019 / 07:00 - GlobeNewswire
•  
• Novartis presents first-of-its-kind histology data with iscalimab (CFZ533) suggesting the extended survival of transplanted organs may be possible
  06/06/2019 / 07:15 - GlobeNewswire
•  
• Long-term survival benefit shown for metastatic melanoma patients treated with Novartis Tafinlar® + Mekinist®
  06/04/2019 / 19:00 - GlobeNewswire